{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T22:05:02Z","timestamp":1769465102098,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jemermed.2007.11.056","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T05:59:32Z","timestamp":1214373572000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Should Acute Treatment with Inhaled Beta Agonists be Withheld from Patients with Dyspnea Who May Have Heart Failure?"],"prefix":"10.1016","volume":"40","author":[{"given":"Carley Ann","family":"Maak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana E.","family":"McClintock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2007.11.056_bib1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.amjcard.2005.07.064","article-title":"United States emergency department visits for acute decompensated heart failure, 1992 to 2001","volume":"96","author":"Hugli","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib2","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1056\/NEJMcp052699","article-title":"Acute pulmonary edema","volume":"353","author":"Ware","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib3","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1001\/jama.294.15.1944","article-title":"Does this dyspneic patient in the emergency department have congestive heart failure?","volume":"294","author":"Wang","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2007.11.056_bib4","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1378\/chest.123.6.1964","article-title":"Risk of mortality and heart failure exacerbations associated with inhaled \u03b2-adrenoceptor agonists among patients with known left ventricular systolic dysfunction","volume":"123","author":"Au","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2007.11.056_bib5","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of \u03b2-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2007.11.056_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00002512-200421060-00005","article-title":"Cardiovascular safety of beta 2-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review","volume":"21","author":"Salpeter","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jemermed.2007.11.056_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jama.287.7.890","article-title":"Beta-blockers in heart failure","volume":"287","author":"Farrell","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2007.11.056_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00005344-200207000-00017","article-title":"Chronically inhaled salmeterol improves pulmonary function in heart failure","volume":"40","author":"Ng","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2796.1998.00291.x","article-title":"Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease","volume":"243","author":"Rossinen","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-8703(81)90221-0","article-title":"Hemodynamic effects of inhaled terbutaline in congestive heart failure patients without lung disease: beneficial cardiotonic and vasodilator beta-agonist properties evaluated by ventricular catherterization and radionuclide angiography","volume":"101","author":"Slutsky","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/eurheartj\/14.6.744","article-title":"Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure","volume":"14","author":"Uren","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cardfail.2003.08.007","article-title":"The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry","volume":"10","author":"Witte","year":"2004","journal-title":"J Card Failure"},{"key":"10.1016\/j.jemermed.2007.11.056_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.CIR.63.1.96","article-title":"Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure","volume":"63","author":"Awan","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2007.11.056_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9149(81)90552-X","article-title":"Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure","volume":"47","author":"Awan","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0002-8703(81)90744-4","article-title":"Therapeutic efficacy of oral pirbuterol in severe chronic congestive failure: acute hemodynamic and long-term ambulatory evaluation","volume":"102","author":"Awan","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/0002-8703(82)90055-2","article-title":"Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure","volume":"104","author":"Awan","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-8703(81)90747-X","article-title":"Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure","volume":"102","author":"Canepa-Anson","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-8703(81)90745-6","article-title":"Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure","volume":"102","author":"Colucci","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.282.6274.1423","article-title":"Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses","volume":"282","author":"Dawson","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"Suppl D","key":"10.1016\/j.jemermed.2007.11.056_bib20","first-page":"135","article-title":"Clinical studies with beta 2 adrenoceptor agonists in heart failure","volume":"3","author":"Dawson","year":"1982","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1475-097X.1991.tb00451.x","article-title":"Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure","volume":"11","author":"Keller","year":"1991","journal-title":"Clin Physiol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0002-8703(85)90648-9","article-title":"Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure","volume":"109","author":"Mettauer","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-8703(82)90433-1","article-title":"Hemodynamic effects of salbutamol, an oral long-acting beta-stimulant, in patients with congestive heart failure","volume":"104","author":"Mifune","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0002-8703(83)90047-9","article-title":"Acute and long-term hemodynamic effects of oral pirbuterol in patients with chronic severe congestive heart failure: randomized double blind trial","volume":"106","author":"Pamelia","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.CIR.64.1.139","article-title":"Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure","volume":"64","author":"Rude","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2007.11.056_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-8703(81)90741-9","article-title":"Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure","volume":"102","author":"Sharma","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1378\/chest.79.5.501","article-title":"Left ventricular size and function after subcutaneous administration of terbutaline","volume":"79","author":"Slutsky","year":"1981","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2007.11.056_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0167-5273(84)90110-4","article-title":"Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study","volume":"5","author":"Timmis","year":"1984","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib29","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0002-8703(82)90434-3","article-title":"Beneficial hemodynamic effects of intravenous terbutaline in patients with severe heart failure","volume":"1982","author":"Wang","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/j.1552-4604.1983.tb02749.x","article-title":"Myocardial metabolic effects of intravenous terbutaline in patients with severe heart failure due to coronary artery disease","volume":"23","author":"Wang","year":"1983","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib31","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.CIR.66.6.1262","article-title":"Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure","volume":"66","author":"Weber","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2007.11.056_bib32","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199206183262503","article-title":"Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function","volume":"326","author":"Cabanes","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM198905183202005","article-title":"Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function","volume":"320","author":"Cabanes","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1378\/chest.78.5.753","article-title":"Special report: respiratory muscles: the vital pump","volume":"78","author":"Macklem","year":"1980","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2007.11.056_bib35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI111065","article-title":"Regional blood flow distribution in dog during induced hypotension and low cardiac output","volume":"72","author":"Viires","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jemermed.2007.11.056_bib36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJM198209233071304","article-title":"Medical progress: the respiratory muscles","volume":"307","author":"Roussos","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1152\/jappl.1999.87.1.30","article-title":"Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia","volume":"87","author":"Sald\u00edas","year":"1999","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1164\/ajrccm.162.1.9809058","article-title":"\u03b2-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury","volume":"162","author":"Sald\u00edas","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/01.CCM.0000129489.34416.0E","article-title":"Clinically relevant concentrations of \u03b22-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury","volume":"32","author":"McAuley","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1152\/jappl.2000.89.4.1255","article-title":"\u03b2-Adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats","volume":"89","author":"Frank","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jemermed.2007.11.056_bib41","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.CCM.0000130825.84691.E2","article-title":"\u03b22-agonists for treatment of pulmonary edema: ready for clinical studies?","volume":"32","author":"Mutlu","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.200508-1302OC","article-title":"The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial","volume":"173","author":"Perkins","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jemermed.2007.11.056_bib43","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/cc3025","article-title":"Extravascular lung water in patients with severe sepsis: a prospective cohort study","volume":"9","author":"Martin","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.jemermed.2007.11.056_bib44","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2007.11.056_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bmj.280.6212.435","article-title":"Synergistic effects of a combined salbutamol-nitroprusside regimen in acute myocardial infarction and severe left ventricular failure","volume":"280","author":"Fowler","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.jemermed.2007.11.056_bib46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467908001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467908001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:21:04Z","timestamp":1760026864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467908001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0736467908001212"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2007.11.056","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Acute Treatment with Inhaled Beta Agonists be Withheld from Patients with Dyspnea Who May Have Heart Failure?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2007.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}